Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Smoking Cessation 1 Prostatic Neoplasms 1 Neoplasms 1 Hematuria 1 Carcinoma, Transitional Cell 1

Interventions

enzalutamide 94 Magnetic Resonance Spectroscopy 86 Specimen Handling 66 Prednisone 66 Androgen Antagonists 60 Abiraterone Acetate 58 apalutamide 56 Radiosurgery 53 darolutamide 48 Radiotherapy 47 Leuprolide 47 abiraterone 46 Docetaxel 43 Pluvicto 32 Radiation 31 Biopsy 31 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30 Surveys and Questionnaires 29 relugolix 28 pembrolizumab 26 gallium 68 PSMA-11 26 Standard of Care 26 Triptorelin Pamoate 25 Goserelin 25 bicalutamide 23 Gonadotropin-Releasing Hormone 23 Brachytherapy 21 Carboplatin 20 cabazitaxel 19 X-Rays 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Urinalysis × 1 year × Clear all

NCT03568188 2026-02-24

FOCALE

Hospices Civils de Lyon

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡